GE, Thomson Reuters Target Comparative Effectiveness Research

GE Healthcare and Thomson Reuters have built a research data repository to support comparative effectiveness research to identify best treatment practices for discrete patient populations.


GE Healthcare and Thomson Reuters have built a research data repository to support comparative effectiveness research to identify best treatment practices for discrete patient populations.

The initiative combines millions of de-identified claims for outcomes research from Thomson Reuters' MarketScan Research Databases with de-identified clinical data from more than 20 million electronic health records from GE Healthcare clients participating in a quality improvement consortium the vendor launched in 2005.

With the combined data, for example, a research study can link claims data from a population of patients diagnosed with a specific condition with clinical data covering body mass index, blood pressure, symptoms and other factors to gain new knowledge into treatment protocols, according to the vendors.

The companies have formed a partnership to provide research and analytical services to assess the effectiveness of treatments, prescription adherence and disease management initiatives covering inpatient and ambulatory services.

GE Healthcare and Thomson Reuters are recruiting customers and planning studies to demonstrate the value of the new service. For more information, send email to cds@ge.com or marketscan@thomsonreuters.com.

--Joseph Goedert